AMA Releases Vaccine Code Changes

AMA Releases Vaccine Code Changes

The American Medical Association (AMA) recently posted a short list of new and revised vaccine codes on their website. These codes are effective July 1, 2017, and will appear in the CPT® 2018 codebook:

90587 Dengue vaccine, quadrivalent, live, 3 dose schedule, for subcutaneous use

  • This is a new code, pending FDA approval.

90620 Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB4C), 2 dose schedule, for intramuscular use

  • This is a revised and resequenced code.

90621 Meningococcal recombinant lipoprotein vaccine, serogroup B (MedB-FHbp), 2 or 3 dose schedule, for intramuscular use

  • This is a revised and resequenced code.

90651 Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavolent (9vHPV), 2 or 3 dose schedule, for intramuscular use

  • This is a revised code.

New Code for 2018

CPT® code 90756 Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use was accepted by the CPT Editorial Panel at the June 2017 meeting for the 2018 production cycle.

 

 

Renee Dustman

Renee Dustman

Executive Editor at AAPC
Renee Dustman, BS, is an executive editor at AAPC. She holds a Bachelor of Science degree in Media Communications - Journalism. She has more than 20 years experience in print publishing, working in production management and content management. She is also a freelance writer and graphic artist.
Renee Dustman

About Has 504 Posts

Renee Dustman, BS, is an executive editor at AAPC. She holds a Bachelor of Science degree in Media Communications - Journalism. She has more than 20 years experience in print publishing, working in production management and content management. She is also a freelance writer and graphic artist.

Leave a Reply

Your email address will not be published. Required fields are marked *